Central banks: are we going under again?
9 mins. to read
After more than 10 years without an interest-rate cut, the Federal Reserve is set to loosen monetary policy − but how far are policymakers willing to go?
Latest from our blog
Read more
Epwin Group is a ‘steady improver’
3 mins. to read
Epwin Group – on 7.5 times pe, yielding 6.8% and offering 33% price upside, these shares are cheap, writes Mark Watson-Mitchell.
Evil Diaries
Evil Knievil: Give us this day our Daley bread
1 mins. to read
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Evil Knievil: Oil is well
1 mins. to read
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Financial News
Read more
NMC Health’s half-year check up shows good progress
1 mins. to read
The price of shares in private healthcare provider NMC Health has risen by 25.81% after its EBITDA climbed by 22.5% during the first half of 2019.
John Laing down as renewables suffer in the first six months
1 mins. to read
John Laing has seen its share price drop by 6.20% following the publication of a mixed set of results for the six months to 30th June.
Equities
Read more
Epwin Group is a ‘steady improver’
3 mins. to read
Epwin Group – on 7.5 times pe, yielding 6.8% and offering 33% price upside, these shares are cheap, writes Mark Watson-Mitchell.
Novo Nordisk – the anatomy of a good company
7 mins. to read
Jamie Ross, fund manager of Henderson EuroTrust, explains the rationale behind the inclusion of the Danish pharmaceutical company Novo Nordisk in his portfolio.
Trading
Read more
Is silver’s slump finally over?
5 mins. to read
Veteran trader David Jones looks at silver and how investors can profit from a recovery in the price of this precious metal.
Is this the start of a new bull market for gold?
4 mins. to read
As gold springs back to life, David Jones investigates whether this is a time to take profits or to prepare for a much bigger move over the longer term.
Economics & Markets
Read more
Central banks: are we going under again?
9 mins. to read
After more than 10 years without an interest-rate cut, the Federal Reserve is set to loosen monetary policy − but how far are policymakers willing to go?
Full speed ahead for carbon capture – investors need to get onboard
15 mins. to read
Most environmentalists emphasise the need to reduce CO2 emissions, but few talk about carbon capture. This is emerging as an important new industry, writes Victor Hill.
Commodities
Read more
Why I’m buying Shanta and keeping an eye on Kefi but avoiding Hummingbird
8 mins. to read
With gold on the ascent, John Cornford explains why he’s buying Shanta and keeping a close eye on Kefi but avoiding Hummingbird.
Is silver’s slump finally over?
5 mins. to read
Veteran trader David Jones looks at silver and how investors can profit from a recovery in the price of this precious metal.
Funds & Investment Trusts
Read more
Strong start for the Smithson Investment Trust
2 mins. to read
Smithson, the largest investment trust at launch, has delivered impressive returns for all those who subscribed to the IPO, writes Nick Sudbury.
BMO Commercial Property Trust: a Brexit bargain
3 mins. to read
The prospect of a hard Brexit on 31 October has created pockets of value amongst the domestically-oriented parts of the UK market.
Brexit
Read more
Brexit – a guide for the perplexed
25 mins. to read
What are the chances that Brexit will be postponed or even reversed altogether? And if it does take place – which type of Brexit will it be and who will be the winners and losers in the corporate world? Victor Hill investigates.
News from Euroland – recession imminent
17 mins. to read
Eurozone economies are slowing. Meanwhile, the May-Barnier deal Brexit looks dead in the water. What would happen if a Eurozone recession coincided with a no-deal Brexit? Victor Hill thinks it’s time to batten the hatches.
Partner Content
Read more
Novo Nordisk – the anatomy of a good company
7 mins. to read
Jamie Ross, fund manager of Henderson EuroTrust, explains the rationale behind the inclusion of the Danish pharmaceutical company Novo Nordisk in his portfolio.
Having bond exposure in a world of uncertainty
4 mins. to read
For an investor looking for income, the ability to invest in both equities and bonds can be beneficial, particularly in the current investment climate, says David Smith, Fund Manager of Henderson High Income Trust.